Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
OACC
Oaktree Acquisition Corp III Life Sciences is a blank check company.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$10.73 – $10.73
Volume7
Market cap—
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for OACC.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for OACC.
Recent news
Company coverage with links to the original publishers.
Verona Pharma reported strong financial results for Q4 and 2024, with its product Ohtuvayre (ensifentrine) recording net sales of $36.6 million in Q4 and $42.3 million in 2024. The company also announced an amended strategic financing with Oaktree and OMERS, including a term loan facility increase and access to additional funding.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.